Last month, Demis Hassabis and John Jumper of Google DeepMind were jointly awarded the 2024 Nobel Prize in Chemistry for their development of AlphaFold 3. This AI model can more accurately predict the ...
Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...
The AI tool AlphaFold has been improved so that it can now predict the shape of very large and complex protein structures. Linköping University researchers have also succeeded in integrating ...
The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...
Proteins are the microscopic workhorses of the human body, driving everything from oxygen transport to muscle contraction. Their complex 3D structures dictate their function, and understanding these ...
Artificial intelligence (AI) is reshaping the scientific landscape, offering fantastic solutions to some of the most pressing global challenges. From combating climate change to transforming ...
Demis Hassabis and John Jumper are the developers behind AlphaFold, an algorithmic model that can predict the 3D shape of proteins from their amino acid sequences. The model lets researchers visualize ...
4don MSN
ET@Davos: Google DeepMind CEO Demis Hassabis on China's AI Leap & Limitations, the AGI Myth & More
In this episode of ET@Davos, ET’s Sruthijith KK speaks to Demis Hassabis, CEO of Google DeepMind and Nobel Laureate 2024, on the future of AI. The chess prodigy-turned scientist-turned-AI pioneer ...
Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results